Neil Torbett
Amministratore Delegato presso PhoreMost Ltd.
Provenienza dei contatti di primo grado di Neil Torbett
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Neil Torbett tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Investment Managers | Consultant / Advisor Consultant / Advisor Private Equity Investor | |
Exonate Ltd.
Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Medical/Nursing Services | Director/Board Member Founder | |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder | |
HORIZON DISCOVERY GROUP PLC | Medical Specialties | Director/Board Member Founder | |
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member Chief Investment Officer | |
Morningside Venture Investments Ltd.
Morningside Venture Investments Ltd. Investment ManagersFinance Part of Morningside Group Ltd., Morningside Venture Investments Ltd. is a There is no available country named vg company that provides investment services. The company is based in Road Town, British Virgin Islands. The company was founded by Gerald Chan. | Investment Managers | Founder | |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Biotechnology | Director/Board Member | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Director/Board Member | |
Morningside Technology Advisory, LLC | Corporate Officer/Principal | ||
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc. BiotechnologyHealth Technology Cognito Therapeutics, Inc. is a clinical-stage neurotechnology company based in Cambridge, MA. Cognito Therapeutics is developing disease-modifying therapeutic approaches to treat neurodegenerative disorders using its non-invasive neuromodulation platform. The company's lead therapy is currently in a pivotal study (HOPE) in Alzheimer's disease and has been awarded FDA breakthrough device designation. Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases. The company was founded by Li-Huei Tsai and Ed Boyden, and Brent A. Vaughan has been the CEO of the company since 2020. | Biotechnology | Chairman | |
LUMIRADX LIMITED | Medical Specialties | Director/Board Member | |
Morningside Group Ltd. (United States)
Morningside Group Ltd. (United States) Financial ConglomeratesFinance Part of Morningside Group Ltd., the company is a biotechnology firm based in Newton Center, MA. The company provides innovative solutions for drug discovery and development, with a focus on cancer and rare diseases. Morningside Group Ltd. (United States) provides investment services. The company was founded by Gerald Chan. | Financial Conglomerates | Founder | |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Pharmaceuticals: Major | Director/Board Member | |
STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Chairman | |
East Carolina University | College/University | Doctorate Degree | |
Synchroneuron, Inc.
Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Major | Director/Board Member | |
MatriVAX, Inc.
MatriVAX, Inc. Pharmaceuticals: MajorHealth Technology MatriVAX, Inc. operates as a biotechnology company. It develops technologies for simplified, low-cost production of vaccines against polysaccharide antigens from pathogenic bacteria. The company was founded by Yichen Lu and John Mekalanos in 2007 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Morningside Foundation | Director/Board Member | ||
Morningside College | College/University | Corporate Officer/Principal | |
NUCANA PLC | Biotechnology | Director/Board Member | |
Oxyrane UK Ltd.
Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Canopy Education, Inc.
Canopy Education, Inc. Miscellaneous Commercial ServicesCommercial Services Canopy Education, Inc. engages in the operation of a mentorship, test preparation and college consulting firm. It offers college and elite application programs, college essay assistance, school list creation and subject tutoring services. The company was founded by Zack Perkins, Johan Zhang, Mohan Zhang, and Vinay Bhaskara in 2013 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Fudan University | College/University | Director/Board Member | |
Council on Foreign Relations, Inc.
Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Director/Board Member | |
KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
The Chinese University of Hong Kong | College/University | Chairman | |
InSilixa, Inc.
InSilixa, Inc. SemiconductorsElectronic Technology Insilixa, Inc. develops molecular diagnostic platform. It offers CMOS biochips for microarray technology, qPCR, and DNA sequencing. The company was founded by Arun Manickam and Arjang Hassibi in 2012 and is headquartered in Sunnyvale, CA. | Semiconductors | Director/Board Member | |
The International Society for Stem Cell Research | Corporate Officer/Principal | ||
APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Amadeus Capital Partners Ltd.
Amadeus Capital Partners Ltd. Investment ManagersFinance Amadeus Capital Partners Ltd is an independent venture capital firm is founded by Anne Glover and Hermann Hauser in 1997. The firm is headquartered in London, UK. | Investment Managers | Founder | |
The Johns Hopkins University | College/University | Corporate Officer/Principal | |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Extension School | College/University | Undergraduate Degree | |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Stingray Bio Ltd. is a British biotechnology research company founded in 2020. The company is based in Brighton, UK. The company provides research services in the field of biotechnology. | Miscellaneous Commercial Services | Director/Board Member | |
Victoria Innovations Ltd. | Director/Board Member | ||
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Albert Innovations Ltd. | Director/Board Member | ||
Predictimmune Ltd.
Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
MIRRIAD ADVERTISING PLC | Advertising/Marketing Services | Director/Board Member | |
Parkwalk Advisors Ltd.
Parkwalk Advisors Ltd. Investment ManagersFinance Parkwalk Advisors Ltd. provides investment advisory services. The company was founded by Alastair Kilgour in 2009 and is headquartered in London, the United Kingdom. | Investment Managers | Founder | |
First Light Fusion Ltd.
First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Parkwalk Advisors Ltd. (Venture Capital)
Parkwalk Advisors Ltd. (Venture Capital) Investment ManagersFinance Parkwalk Advisors Ltd. (Parkwalk Advisors) is a venture capital firm founded in 2009 by Moray Wright and Alastair Hugh Lowell Kilgour. The firm is headquartered in London, United Kingdom. | Investment Managers | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 25 |
Regno Unito | 23 |
Isole Cayman | 2 |
Cina | 2 |
Hong Kong | 2 |
Settori
Health Technology | 19 |
Commercial Services | 10 |
Consumer Services | 8 |
Finance | 7 |
Health Services | 3 |
Posizioni
Director/Board Member | 91 |
Founder | 27 |
Corporate Officer/Principal | 20 |
Chairman | 18 |
Chief Tech/Sci/R&D Officer | 6 |
Contatti più connessi
- Borsa valori
- Insiders
- Neil Torbett
- Connessioni Società